Literature DB >> 14983407

Relationship between 25-(OH) D3, the IGF-I system, leptin, anthropometric and body composition variables in a healthy, randomly selected population.

J M Gómez1, F J Maravall, N Gómez, M A Navarro, R Casamitjana, J Soler.   

Abstract

OBJECTIVE: This study prompted us to investigate the relationship between 25-(OH) D (3) and the IGF-I system, leptin, sex, age, anthropometric and body composition variables in healthy adults. We hypothesised that these variables would regulate 25-(OH) D (3) concentrations.
DESIGN: We included 253 subjects--126 men and 127 women. Body mass index (BMI) and body composition was determined, along with serum leptin, total IGF-I, free IGF-I, IGFBP3 and plasma 25-(OH) D (3) concentrations.
RESULTS: 25-(OH) D (3) deficiency was observed in 69 subjects. There was a difference between 25-(OH) D (3) values and season (summer vs. winter). We observed similar 25-(OH) D (3) concentrations in men to those in women. The differential characteristics in subjects without 25-(OH) D (3) deficiency were lower BMI, fat mass and body fat and higher free IGF-I. We observed that leptin increased in the last decades and IGF-I system decreased by decade in both men and women. In subjects without 25-(OH) D (3) deficiency, there was a correlation between free IGF-I and 25-(OH) D (3) in men, and a negative correlation between 25-(OH) D (3) and age, BMI, fat mass and leptin and a positive correlation with total IGF-I in women. The multivariate linear regression analysis explained 37.8 % of 25-(OH) D (3) variability in men and 39 % in women, and only season and free IGF-I made an independent contribution to 25-(OH) D (3) in men, and season and fat mass in women.
CONCLUSION: These data suggest that free IGF-I in men and fat mass in women could regulate 25-(OH) D (3) concentrations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14983407     DOI: 10.1055/s-2004-814103

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  18 in total

1.  Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance.

Authors:  A Deleskog; A Hilding; K Brismar; A Hamsten; S Efendic; C-G Östenson
Journal:  Diabetologia       Date:  2012-03-17       Impact factor: 10.122

2.  Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects.

Authors:  F Bogazzi; G Rossi; M Lombardi; L Tomisti; C Sardella; L Manetti; O Curzio; C Marcocci; L Grasso; M Gasperi; E Martino
Journal:  J Endocrinol Invest       Date:  2010-07-29       Impact factor: 4.256

3.  Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D?

Authors:  Maria Cristina Savanelli; Elisabetta Scarano; Giovanna Muscogiuri; Luigi Barrea; Laura Vuolo; Manila Rubino; Silvia Savastano; Annamaria Colao; Carolina Di Somma
Journal:  Endocrine       Date:  2015-10-29       Impact factor: 3.633

4.  Neonatal vitamin D and childhood brain tumor risk.

Authors:  Parveen Bhatti; David R Doody; Roberta Mckean-Cowdin; Beth A Mueller
Journal:  Int J Cancer       Date:  2014-11-09       Impact factor: 7.396

5.  Gender dependent association of 25-hydroxyvitamin D and circulating leptin in saudi subjects: influence of dyslipidemia.

Authors:  Nasser M Al-Daghri; Shakilur Rahman; Osama E Amer; Omar S Al-Attas; Philip G McTernan; Majed S Alokail
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  Vitamin D and serum leptin: a systematic review and meta-analysis of observational studies and randomized controlled trials.

Authors:  M Hajimohammadi; S Shab-Bidar; T R Neyestani
Journal:  Eur J Clin Nutr       Date:  2016-12-14       Impact factor: 4.016

7.  Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Wei Zheng; Kim N Danforth; Shelley S Tworoger; Marc T Goodman; Alan A Arslan; Alpa V Patel; Marjorie L McCullough; Stephanie J Weinstein; Laurence N Kolonel; Mark P Purdue; Xiao-Ou Shu; Kirk Snyder; Emily Steplowski; Kala Visvanathan; Kai Yu; Anne Zeleniuch-Jacquotte; Yu-Tang Gao; Susan E Hankinson; Chinonye Harvey; Richard B Hayes; Brian E Henderson; Ronald L Horst; Kathy J Helzlsouer
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

8.  Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables.

Authors:  N Vilarrasa; J Maravall; A Estepa; R Sánchez; C Masdevall; M A Navarro; P Alía; J Soler; J M Gómez
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

9.  Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery.

Authors:  José Manuel Gómez; Núria Vilarrasa; Carles Masdevall; Jordi Pujol; Esther Solano; Juan Soler; Iñaki Elio; Lluis Gallart; Joan Vendrell
Journal:  Obes Surg       Date:  2008-04-29       Impact factor: 4.129

10.  Circulating vitamin d and risk of epithelial ovarian cancer.

Authors:  Alan A Arslan; Tess V Clendenen; Karen L Koenig; Johan Hultdin; Kerstin Enquist; Asa Agren; Annekatrin Lukanova; Hubert Sjodin; Anne Zeleniuch-Jacquotte; Roy E Shore; Göran Hallmans; Paolo Toniolo; Eva Lundin
Journal:  J Oncol       Date:  2009-08-27       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.